Transforming Cardiac
Surgery Through Innovation

Delivering state of the art solutions from the heart of clinical practice in pursuit of optimal cardiothoracic surgery outcomes.

A complex problem with a simple solution: PerDeCT™

Although cardiac surgery is largely safe, some patients develop a life-threatening condition called cardiac tamponade in the immediate postoperative period.

Cardiac tamponade is caused by the collection of blood clots in the pericardial space compressing the heart and compromising the cardiac output.

The diagnosis of tamponade is subjective, difficult, typically happens late at night and can be confused with other causes of heart failure.

The PerDeCT™ device can save lives, improve patient outcomes, reduce overall costs, and has an attractive health economic case for medical device manufacturers.

Patient and User Feedback

  • Key Opinion Leader
    Older, sicker patients demand better myocardial protection. The results (of polarized cardioplegia) are promising and underline the potential of polarised arrest.

    Key Opinion Leader

  • End User - Expression of Interest
    If this is shown to be a reliable cardiac monitoring device that could be placed on the PA after surgery and easily removed, I would use it in every patient.

    End User - Expression of Interest

  • Patient's Spouse
    XXX had straightforward mitral valve operation and developed tamponade. I was next to her when her heart stopped, they ushered me out and drew the curtains to open her up on the intensive care unit. This will remain the most traumatic experience in my life. I thought I lost her. Now I know XXX was lucky to have survived. This device should be available to every patient because this should not happen to anyone.

    Patient's Spouse

  • Perfusion Lead, Major Hospital
    Cardioplegia has been plagued with supply issues and we do not seem to get what we want. The way we are preparing it is a recipe for errors.

    Perfusion Lead, Major Hospital

*PerDeCT detects tamponade early and STHpol offers superior myocardial protection

Meet Our Team

Dr Hazem Fallouh FRCS

CEO


Cardiothoracic surgeon, inventor and founder.

Joshua Purchase MSc

Project Lead


MRes Cardiovascular Sciences and Imaging. Researcher with Medical Devices experience

Simon Manning

Finance Director


Chartered accountant with 15+ years experience in Pharma.

Dr Asma Djabri PhD

Regulatory Affairs


Former Head Pharmacist at Guys & St Thomas Hospital

Partners & Advisors

Prof. Tom Clutton-Brock

PerDeCT Project Partner (Innovate UK)


Prof. Alex Rothman

PerDeCT Project Partner (Innovate UK)


Recent News from Fallouh Healthcare

Get in touch to learn more.

For investors or research partner enquiries, please mention this in the email subject.